We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+12.4%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$335M
AUM Growth
+$66.6M
Cap. Flow
+$40.8M
Cap. Flow %
12.18%
Top 10 Hldgs %
10.51%
Holding
476
New
121
Increased
122
Reduced
81
Closed
105

Top Buys

Rank Stock Value
1
MGRC icon
McGrath RentCorp
MGRC
+$2.84M
2
HGV icon
Hilton Grand Vacations
HGV
+$2.81M
3
SCS
Steelcase
SCS
+$2.56M
4
FBP icon
First Bancorp
FBP
+$2.21M
5
NSP icon
Insperity
NSP
+$2.16M

Top Sells

Rank Stock Value
1
AXE
Anixter International Inc
AXE
+$3.4M
2
KEYS icon
Keysight
KEYS
+$2.72M
3
MTZ icon
MasTec
MTZ
+$2.7M
4
GMS
GMS Inc
GMS
+$2.48M
5
HD icon
Home Depot
HD
+$2.29M

Sector Composition

Rank Sector Weight
1 Industrials 19.63%
2 Technology 18.16%
3 Healthcare 15.63%
4 Consumer Discretionary 14.53%
5 Financials 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VG
351
DELISTED
Vonage Holdings Corporation
VG
$96K 0.03%
+12,948
New +$112K
PZN
352
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$90K 0.03%
10,440
-1,220
-10% -$10.5K
ELVT
353
DELISTED
Elevate Credit, Inc.
ELVT
$86K 0.03%
19,397
OVID icon
354
Ovid Therapeutics
OVID
$444M
$81K 0.02%
+19,590
New +$61.9K
ITI
355
DELISTED
Iteris, Inc.
ITI
$80K 0.02%
+15,970
New +$81.3K
HBIO icon
356
Harvard Bioscience
HBIO
$27.6M
$79K 0.02%
2,596
-3,706
-59% -$107K
EPM icon
357
Evolution Petroleum
EPM
$143M
$71K 0.02%
13,020
-8,140
-38% -$44.8K
ADMA icon
358
ADMA Biologics
ADMA
$1.94B
$70K 0.02%
+17,400
New +$75.8K
LEE icon
359
Lee Enterprises
LEE
$179M
$61K 0.02%
4,263
-915
-18% -$16.3K
SEAC
360
DELISTED
Seachange International Inc
SEAC
$61K 0.02%
+727
New +$49.4K
CSLT
361
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$61K 0.02%
45,569
+25,866
+131% +$36.1K
NEOS
362
DELISTED
Neos Therapeutics, Inc
NEOS
$52K 0.02%
34,254
-37,981
-53% -$57K
ARAY icon
363
Accuray
ARAY
$28.7M
$51K 0.02%
17,946
-68,135
-79% -$189K
BLCM
364
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$47K 0.01%
3,681
-5,376
-59% -$49.6K
PVLA
365
Palvella Therapeutics
PVLA
$2.04B
$40K 0.01%
138
-125
-48% -$34.7K
CNSL
366
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$40K 0.01%
10,400
GNSS icon
367
Genasys
GNSS
$77M
$35K 0.01%
10,587
-5,871
-36% -$19.9K
HPR
368
DELISTED
HighPoint Resources Corporation
HPR
$29K 0.01%
+343
New +$22.3K
VIRX
369
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$23K 0.01%
1,915
SYNC
370
DELISTED
Synacor, Inc.
SYNC
$21K 0.01%
13,890
-2,110
-13% -$3.3K
APVO icon
371
Aptevo Therapeutics
APVO
$5.55M
0
ABBV icon
372
AbbVie
ABBV
$448B
-5,396
Closed -$409K
ABG icon
373
Asbury Automotive
ABG
$4.16B
-8,417
Closed -$861K
ACAD icon
374
Acadia Pharmaceuticals
ACAD
$4.27B
-7,370
Closed -$265K
AFL icon
375
Aflac
AFL
$62.9B
-8,546
Closed -$447K

Similar funds

Algert Global's Q4 2019 Portfolio in Review

As of Q4 2019, Algert Global held 476 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Algert Global deployed $40.8M of net new capital in Q4 2019, opening 121 new positions and adding to 122 existing holdings. Its largest new stake was McGrath RentCorp: 39,097 shares worth $2.99M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was MasTec, an estimated $2.7M trimmed.

  • Algert Global's largest Q4 2019 buy was McGrath RentCorp: 39,097 shares worth $2.99M.
  • Algert Global added most to ePlus in Q4 2019, an estimated $2.08M increase.
  • Algert Global's biggest Q4 2019 reduction was MasTec, cutting an estimated $2.7M.
  • Algert Global fully exited Anixter International Inc in Q4 2019, selling an estimated $3.4M.
  • Algert Global's ten largest holdings make up 11% of its $335M portfolio in Q4 2019.
  • Algert Global opened 121 new positions and closed 105 in Q4 2019.
  • Algert Global's portfolio value rose 25% quarter-over-quarter to $335M.

Based on Algert Global's 13F filing for Q4 2019, filed 18 Feb 2020.